Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q3 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.